4th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference
The 4th Annual Biomarker and Companion Diagnostics Conference to be held in The Westin San Diego Gaslamp Quarter, CA on the 7th-8th February 2019 will host industry giants like Novartis, Pfizer, Takeda, Invivoscribe and Genzyme Sanofi to present their Biomarker and Companion Diagnostics case studies. The main aim of the conference is to address the gaps between early stage biomarker development and the commercialization stage of biomarkers.
MarketsandMarkets presents to you The 4th Annual Biomarker and Companion Diagnostics Conference to be held on 7th-8th February 2019 in San Diego, CA. The 2-day event will gather 10+ sponsors, 25+ leading industry speakers and 150+ professional working on Biomarkers, Companion Diagnostics and personalized medicine.
With overall 3 sessions, the primary focus of the agenda will be on Clinical biomarker identification and qualification, Assay development and validation, NGS and novel technologies in biomarker discovery and Commercialization of biomarkers in therapeutic and CDx applications. The expected attendance of delegates will see global leading industry professionals from Pharmaceutical companies, Bio-pharma companies, Universities and Research institutes.
Contact: Amit Shelke
Contact Email: email@example.com
The Westin San Diego Gaslamp Quarter
910 Broadway Cir, San Diego, CA 92101, USA